Log in to your Inderes Free account to see all free content on this page.
Vivesto
0.263
SEK
-1.32 %
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
-1.32%
-0.19%
+1.35%
-13.65%
-35.58%
+39.78%
-87.45%
-93.6%
-98.55%
www.vivesto.com/en
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.26 / 0.27
SEK
Market cap
141.24M SEK
Turnover
54.69K SEK
Volume
207K
Latest videos
Financial calendar
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Per Arwidsson med bolag | 24.8 % | 24.8 % |
| Avanza Pension | 5.7 % | 5.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vivesto signs Apealea option agreement with Zhida Pharmaceutical
Vivesto receives positive Cantrixil preclinical efficacy data
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio